TYRO3 and thyroid cancer: We found that DPP4, TIMP1 and TYRO3 were associated with a better prognosis and survival in patients with thyroid cancer, while FABP4, NR4A1 and SNCA were associated with a poor prognosis and survival in patients with thyroid cancer (Figure 4).